171 related articles for article (PubMed ID: 18171234)
1. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
[No Abstract] [Full Text] [Related]
2. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.
Gazzola L; Tincati C; Bellistrì GM; Monforte Ad; Marchetti G
Clin Infect Dis; 2009 Feb; 48(3):328-37. PubMed ID: 19123868
[TBL] [Abstract][Full Text] [Related]
3. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
[TBL] [Abstract][Full Text] [Related]
4. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
Kolber MA
AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
[TBL] [Abstract][Full Text] [Related]
5. HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.
Rauch A; Nolan D; Furrer H; McKinnon E; John M; Mallal S; Gaudieri S; Günthard HF; Schmid P; Battegay M; Hirschel B; Telenti A; James I;
Clin Infect Dis; 2008 Jun; 46(12):1921-5. PubMed ID: 18466093
[TBL] [Abstract][Full Text] [Related]
6. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
7. Class of antiretroviral therapy and CD4+ T cell count recovery: independence questioned.
Parienti JJ
Clin Infect Dis; 2009 Feb; 48(3):370; author reply 370-2. PubMed ID: 19128162
[No Abstract] [Full Text] [Related]
8. CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited.
Goicoechea M; Haubrich R
J Infect Dis; 2005 Sep; 192(6):945-7. PubMed ID: 16107944
[No Abstract] [Full Text] [Related]
9. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
10. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
11. A look at HIV immune research. Interview by Alan Huff.
Landay A
Res Initiat Treat Action; 2000 Sep; 6(3):30-3. PubMed ID: 11708165
[No Abstract] [Full Text] [Related]
12. CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.
Geng EH; Deeks SG
Clin Infect Dis; 2009 Feb; 48(3):362-4. PubMed ID: 19123869
[No Abstract] [Full Text] [Related]
13. Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption.
León A; Martinez E; Milinkovic A; Mora B; Mallolas J; Blanco JL; Larrousse M; Laguno M; Gallart T; Plana M; Gatell JM; Garcia F
J Antimicrob Chemother; 2009 Jan; 63(1):184-8. PubMed ID: 19001447
[TBL] [Abstract][Full Text] [Related]
14. Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART.
Manfredi R; Calza L; Chiodo F
AIDS; 2006 Feb; 20(3):455-7. PubMed ID: 16439881
[TBL] [Abstract][Full Text] [Related]
15. [HIV infection: in the HAART era, CD4 makes the difference].
Varsky C
Acta Gastroenterol Latinoam; 2004; 34(3):117-9. PubMed ID: 15742925
[No Abstract] [Full Text] [Related]
16. Negative influence of age on CD4+ cell recovery after highly active antiretroviral therapy in naive HIV-1-infected patients with severe immunodeficiency.
Micheloud D; Berenguer J; Bellón JM; Miralles P; Cosin J; de Quiros JC; Conde MS; Muñoz-Fernández MA; Resino S
J Infect; 2008 Feb; 56(2):130-6. PubMed ID: 18192020
[TBL] [Abstract][Full Text] [Related]
17. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
18. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
[TBL] [Abstract][Full Text] [Related]
19. To kill or be killed: how HIV exhausts the immune system.
Gougeon ML
Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
[No Abstract] [Full Text] [Related]
20. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
Voirin N; Routy JP; Smith D; Baratin D; Trépo C; Cotte L; Touraine JL; Livrozet JM; Cooper DA; Ritter J; André P; Vanhems P
HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
